Flora Growth Corp

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis, Over-the-Counter Medical Products and Medical Cannabis Products, Wellbeing Products, and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Aurora Cannabis

Canopy Growth

For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.

Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks

Fort Lauderdale, Florida--(Newsfile Corp. - May 1, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor, is applauding the reported historic move by the U.S. Drug Enforcement Administration ("DEA") to reclassify cannabis from its list of Schedule I drugs to Schedule III, following a recommendation from the federal Health and Human Services Department ("HHS"). "This expected rescheduling would come shortly after Germany's legalization of recreational cannabis becoming effective earlier in April.

Flora Growth Corp. Applauds Reported Historic DEA Move to Reschedule Cannabis

Acquisition capitalizes on TruHC's strategically built German cannabis platform, including: EU-GMP processing and production license GDP wholesale license for import / export EU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensaries Narcotics license with EU-GMP certified storage EU-GMP certified laboratory for instant cannabis analysis Transaction combines Flora's extensive global CPG and pharmaceutical distribution network with TruHC's deep global cannabis expertise, including an executive team with extensive experience building successful medical and recreational cannabis companies across Germany, Canada, and the United States. Germany poised to become world's largest federally legal cannabis market with expected market potential of over $10 billion with federal legalization and the critical elimination of banking, financial, capital markets, and tax constraints faced by U.S. operators.

Flora Growth Corp. Enters into Definitive Agreement to Acquire TruHC

Fort Lauderdale, Florida--(Newsfile Corp. - April 11, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, is pleased to announce it has entered an exclusive distribution agreement with Me Raw Trade Ltd. ("Me Raw") to distribute both JustCBD and Vessel branded products in Poland.

Flora Growth Enters Distribution Agreement to Expand Presence in Poland and Neighbouring Countries

Fort Lauderdale, Florida--(Newsfile Corp. - April 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, has entered into a strategic distribution agreement with IM Cannabis Corp. ("IMC") for Vessel products in Israel. Vessel is a wholly owned subsidiary of the Company and a market leading brand of vape pens and smoking accessories.

Flora Growth and IM Cannabis to Bring Vessel Products to the Israeli Market

NEW YORK, NY / ACCESSWIRE / April 9, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC). About Flora Growth Corp. Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.

Aegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC)

Panama City, Panama--(Newsfile Corp. - April 8, 2024) - Clifford Starke (the "Acquiror") announces, pursuant to the early warning requirements of Canadian securities legislation, that he has acquired common shares (the "Common Shares") of Flora Growth Corp. ("Flora" or the "Company"), pursuant to the recently completed public offering of the Company (the "Offering"), which was completed on April 8, 2024. As a result of the Offering, the Acquiror acquired an aggregate of 526,315 Common Shares for US$1.00 million or CAD$1.36 million through YT Research Inc., an entity owned and controlled by the Acquiror.

Clifford Starke Acquires Securities of Flora Growth Corp.

Fort Lauderdale, Florida--(Newsfile Corp. - April 8, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, announced the closing of its underwritten public offering (the "Offering") of 1.7 million common shares (the "Common Shares") for aggregate gross proceeds of approximately $3.23 million, prior to deducting underwriting discounts and other offering expenses. The Company's Chief Executive Officer, Clifford Starke, purchased Common Shares in the Offering.

Flora Growth Corp. Announces Closing of $3.2 Million Underwritten Public Offering of Common Shares

Flora Growth (NASDAQ: FLGC ) stock was not part of the April 4 rally in cannabis stocks. It fell 15% overnight after announcing a secondary offering worth $3.2 million.

FLGC Stock: Why Flora Growth Is Down 15% Despite Major Cannabis Rally

Fort Lauderdale, Florida--(Newsfile Corp. - April 4, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, announced the pricing of its underwritten public offering (the "Offering") of 1.7 million common shares (the "Common Shares") for aggregate gross proceeds of approximately $3.23 million, prior to deducting underwriting discounts and other offering expenses. The Company's Chief Executive Officer, Clifford Starke, and an existing investor have agreed to purchase, and have been allocated by Aegis Capital Corp., Common Shares in the Offering.

Flora Growth Corp. Announces Pricing of $3.2 Million Underwritten Public Offering of Common Shares

Fort Lauderdale, Florida--(Newsfile Corp. - April 3, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, today announced that it has commenced a public offering to offer and sell Common Shares. The Company intends to use the net proceeds from this offering for general corporate and working capital needs.

Flora Growth Corp. Announces Launch of Proposed Underwritten Public Offering of Common Shares

Acquisition capitalizes on TruHC's leading German cannabis platform, including: EU-GMP processing and production license GDP wholesale license for import / export EU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensaries Narcotics license with EU-GMP certified storage EU-GMP certified laboratory for instant cannabis analysis Transaction combines Flora's extensive global CPG and pharmaceutical distribution network with TruHC's deep global cannabis expertise, including an executive team with extensive experience building successful medical and recreational cannabis companies across Germany, Canada, and the United States. Germany is expected to become world's largest federally legal cannabis market with expected market potential of over $10 billion with federal legalization and the critical elimination of banking, financial, capital markets, and tax constraints faced by U.S. operators.

New Leader in German Cannabis Created with Acquisition of TruHC, Leading EU-GMP Medical Cannabis Producing Facility, on Historic Day Germany Legalizes Recreational Cannabis

As April 2024 approaches, investors watch the marijuana stock market for potential momentum. The cannabis industry, especially in the U.S., has seen significant growth, driven by legislative advancements and changing public perceptions. This growth trajectory suggests a promising future for the sector, making it an area of interest for both seasoned and novice investors. Companies like Canopy Growth and Aurora Cannabis are among the top stocks to watch as they expand their global footprint. Furthermore, U.S.-based firms are gaining traction thanks to state-level legalization and the potential for federal reforms. These developments create a dynamic market landscape with opportunities for those closely monitoring industry trends and company performances.

April 2024's Green Giants: Leading Stocks in the Cannabis Sector

Fort Lauderdale, Florida--(Newsfile Corp. - March 28, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, is pleased to announce the signing of an exclusive distribution agreement with Althea Group Holdings Limited ("AGH") for Vessel brands in the United Kingdom ("UK"). Vessel is a wholly owned subsidiary of the Company and a market leading brand of vape pens and smoking accessories.

Flora Growth to Partner with Althea Group Holdings on Vessel Distribution in UK

Fort Lauderdale, Florida--(Newsfile Corp. - March 25, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, plans to launch a cannabis home grow kit, start up material seeds and cuttings in Germany in response to the first phase of Germany's new recreational cannabis legalization law. The German legal cannabis recreation market has the potential to reach $4.2 billion upon legalization with the total European market forecasted to achieve revenues of $10.2 billion.

Flora Growth Plans to Expand Leading Global Genetics Business in Germany

Fort Lauderdale, Florida--(Newsfile Corp. - March 22, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, commends Germany's upper house lawmakers for passing the recreational cannabis legalization bill, after it was approved by the lower house last month. The law is now expected to come into effect on April 1, 2024.

Flora Growth Corp. Provides Update on Germany's Cannabis Legalization

As we step into March 2024, the landscape of the U.S. cannabis industry continues to evolve, presenting intriguing opportunities for investors. With states progressively legalizing marijuana for medical and recreational use, the sector is on the brink of significant growth. This burgeoning market is not just about the plant itself but encompasses a range of businesses. These include cultivation, distribution, retail, and technology. Investors are keenly watching top U.S. marijuana stocks. They are looking for those positioned to capitalize on this expansion. The promise of the U.S. cannabis industry, with its anticipated upward trajectory, has caught the eye of many. Analysts predict robust future growth driven by ongoing legalization efforts and increasing societal acceptance.

Cultivating Growth: Top U.S. Marijuana Stocks for March 2024

Fort Lauderdale, Florida--(Newsfile Corp. - February 26, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, applauds the German parliament for voting in favor of legalizing cannabis for recreation use. Flora's wholly-owned subsidiaries have been active in Germany since 2017, obtained the first medical cannabis license in Germany and are responsible for selling the first gram of medical cannabis in the country.

Flora Growth Corp. Applauds Germany's Vote to Legalize Recreational Cannabis

Silver Spike Investment Corp

Tilray Brands

Are you on the hunt for some undervalued cannabis stocks? The government's potential rescheduling of cannabis from Schedule I to Schedule III (or perhaps even descheduling) has been one of the most anticipated catalysts of the cannabis market.

The 3 Most Undervalued Cannabis Stocks to Buy in February 2024

Fort Lauderdale, Florida--(Newsfile Corp. - January 22, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, is pleased to announce that Clifford Starke, the Company's Chief Executive Officer and Director, has been elected as Chairman of the U.S. Hemp Roundtable Board of Directors. "Given the current political environment, momentum is swinging in the right direction.

Flora Growth Corp. To Chair U.S. Hemp Roundtable Board of Directors

Curaleaf Holdings, Inc.

So far marijuana stocks have slowly been having more market momentum. Much of this can be due to several factors that may continue to help. With the 2024 year just starting the anticipation of what's to come could be a reason. Sometimes when there is reason to believe something will help the sector trade people begin to buy and sell more. When people begin to buy and sell are a more consistent pace especially buying it drives the stock price up.

Cannabis Investing: Top Marijuana Stocks To Watch Today

Flora Growth (NASDAQ: FLGC ) stock is on the rise Thursday after the cannabis company announced Restricted Stock Awards (RSAs) for several of its leaders. The company distributed 726,241 RSAs to its leaders as part of its 2022 Equity Compensation Plan.

Why Is Flora Growth (FLGC) Stock Up 7% Today?

Fort Lauderdale, Florida--(Newsfile Corp. - November 8, 2023) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, reported today its financial and operating results for the three and nine months ended September 30, 2023. All financial information is provided in U.S. dollars unless indicated otherwise.

Flora Growth Corp. Reports Record Q3 2023 with Net Income of $1.1 Million and EBITDA of $0.9 Million

Fort Lauderdale, Florida--(Newsfile Corp. - October 16, 2023) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, has announced that Juan Carlos Roa Gomez resigned from his role as Director. About Flora Growth Corp. Flora Growth Corp. is a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution.

Flora Growth Corp. Announces Resignation of Director

Fort Lauderdale, Florida--(Newsfile Corp. - October 2, 2023) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, has announced that Hussein Rakine resigned from his role as Director, but will continue as serve as a Special Advisor to the Company. "I would like to thank Mr.

News for Flora Growth Corp Stock (FLGC)